Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Optimal Dose of Tranexamic Acid in Decreasing Blood Loss During Lower Extremity Total Joint Arthroplasty

NCT02584725 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT02584725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02584725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Optimal Dose of Tranexamic Acid in Decreasing Blood Loss During Lower Extremity Total Joint Arthroplasty
Lead sponsor
Columbia University
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2014
Completion date
June 30, 2015
Enrollment
84 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arthropathy of hip, arthropathy of knee